Successful completion of a CHF 500K fundraising round from business angels.
Founders
Dr. Bisognano Carmelo
Company Description
Exogems is a Swiss biotech company developing therapeutic exosomes derived from microfragmented adipose tissue to treat inflammation, infection, and cancer. The company's innovative approach harnesses the unique properties of exosomes to create targeted, effective, and safe treatments for various diseases.